Steven Cohen Karuna Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$161.01 - $317.85 $45.6 Million - $90 Million
-283,170 Reduced 81.42%
64,630 $20.5 Million
Q3 2023

Nov 14, 2023
BUY
$164.66 - $218.08 $49.7 Million - $65.8 Million
301,860 Added 657.07%
347,800 $58.8 Million
Q2 2023

Aug 14, 2023
SELL
$176.32 - $240.22 $91.3 Million - $124 Million
-517,558 Reduced 91.85%
45,940 $9.96 Million
Q1 2023

May 15, 2023
BUY
$161.33 - $204.36 $78.5 Million - $99.4 Million
486,506 Added 631.89%
563,498 $102 Million
Q4 2022

Feb 14, 2023
SELL
$191.53 - $236.82 $36.6 Million - $45.3 Million
-191,108 Reduced 71.28%
76,992 $15.1 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $33.2 Million - $74.4 Million
268,100 New
268,100 $60.3 Million
Q2 2022

Aug 15, 2022
SELL
$93.97 - $143.33 $18 Million - $27.5 Million
-191,800 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$98.9 - $132.37 $9.76 Million - $13.1 Million
98,703 Added 106.02%
191,800 $24.3 Million
Q4 2021

Feb 14, 2022
BUY
$110.64 - $159.4 $10.3 Million - $14.8 Million
93,097 New
93,097 $12.2 Million
Q4 2019

Feb 14, 2020
SELL
$11.44 - $123.99 $431,711 - $4.68 Million
-37,737 Closed
0 $0
Q3 2019

Nov 15, 2019
BUY
$16.05 - $27.35 $605,678 - $1.03 Million
37,737 New
37,737 $616,000

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email